Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Decided to post here, its been a long while and dropped off due to the FUD.... Hope everyone is well and beating off all the shorts here
Somebody sold 223K shares @ .5750 , probably Day Traders not holding for long weekend.
Meirluc, I pretty much made up my mind on this one, but yea you and others should start now and block all the fudsters here. Why reply and fuel their post, not sure I understand that since probably 95% know the real facts, does no good to respond, that is what they feed off of, there is way to much posting back and forth to them and polluting this board. The neebie's coming on board will see through their crap and they need man up and do DD anyway. Good Luck
Krisgo,
Possible Partnership deals before approval, Nature Article published, Court Case MTD denied and DCVax + Poly-ICLC (NCT01204684) Phase II Study Completion results to name a few
Here is a Catalyst Link that may help you.
https://www.reddit.com/r/NWBO/comments/16ipzhq/nwbo_catalyst_list_update_202324/
mani, my Level 2 screen is always up, yea I am aware of that, 1300 available did not move on multiple purchases well above 1300, almost 15x of that.
Reefrad, how you know they were warrants? I do know the shares I purchased today were hidden and not shown as available to the retail investors. When I purchased 20k and 1300 shown, it stayed 1300 available. No movement. Bought Ask.
insidernews, unfortunately we investors have to tow the line until at least approval and revenue rolls in, that is the nature of beast right now. I am willing to do that until both of those happen, yes, I would like more communication for the pain us investors endure while we wait, but not much we can do to change that. The end game is certainly near.
So ASK @ .5898 , 1300 shares showing, purchased 20000 Shares and ASK stays at 1300, the old hidden share tricks.
Interesting investment of Merck shares by none other than Ken Grifffen and his Hedge Fund.
Citadel Investment Group’s Equity Stake: $687.41 Million
Number of Hedge Fund Holders: 85
Merck & Co., Inc. (NYSE:MRK) is a healthcare company that offers human health pharmaceutical products in oncology, acute care, immunology, neuroscience, cardiovascular health, and diabetes. Merck & Co., Inc. (NYSE:MRK) also develops and markets veterinary pharmaceutical vaccines and health management solutions.
While Merck & Co., Inc. (NYSE:MRK) was flat in 2023, it still contributed to Citadel Investment Group returns owing to its 2.61% dividend yield. Likewise, the hedge fund increased its stake in Merck & Co., Inc. (NYSE:MRK) by 263% in Q3 2023 to $687.41 million.
Well it's not that, does not expire till 2031, but seems there was some sort of update today of the DNS or nameserver from what I can tell. Could be a simple DNS nameserver issue, just not sure. Registrant Contact Information is in Toronto, CA. I do not recall if its always been that way.
DJPele, hope the site being down is for a much needed website update and PR, :)
DI replied to me and then Flipper; being the timeframe of the replies he could certainly have a different opinion now that we sit in 2024, also DI could have been shot down by LP or others on doing a PR on acceptance, just my humble perspective.
IMO most longs probably have enough shares in their treasure chest not buying anymore substantial shares, plus if like me they are getting close to dry powder as well. Take that along with dilution, which I understand is needed to keep the ship afloat until approval and revenues happen, so no issue with that. But no substantial buying, needed dilution, PR silence and waiting on next Catalyst will surely impact SP as we see. MM's and Hedges are doing their part as well to complete the push of the SP low as possible to try to crush the moral of longs.
New Pacer docket 141
Jan 12, 2024
OBJECTION to 137 Report and Recommendations Document filed by Canaccord Genuity LLC, Citadel Securities LLC, G1 Execution Services LLC, GTS Securities LLC, Instinet LLC, Lime Trading Corp., Virtu Americas LLC..(Burck, William) (Entered: 01/12/2024)
Main Doc
Objection to Report and Recommendations
dstock, that tech transfer skill is note worthy for sure. Thank you
Let’s hope it shows up tomorrow and a late filing is not released in the pacer yet.
I am at a loss for words Mr Bull. 🐂
Bio, yea she has medulloblastoma, I was just reading about another lower grade glioma in younger adults and the possible treatment using vorasidenib. Seems it completed phase III and getting ready for submission to FDA. https://www.cancer.gov/news-events/cancer-currents-blog/2023/vorasidenib-low-grade-glioma-idh-mutations
“All patients with these tumors eventually get to the point where they need radiation and chemotherapy,” said study co-leader Timothy Cloughesy, M.D., who directs the UCLA Neuro-Oncology Program. “But watchful waiting is a way to put off doing radiation for a while.”
attilathehunt, Avalon it is, I worked in Alpharetta for many years early 2000, I am about 1.5 hours from there now.
Legend, uh I did just to squash the thought that I was a short or a pumper on the long side.
Bio, you would think someone of his financial resources and connections he would be getting treatment in UK and paying the 200K, although I do not know the specifics if she meets the criteria needed to begin the DCVAX-L treatment.
Horseb4carT, I live in Northern Ga, hopefully we can all celebrate one day, as you mentioned that would be a great time for all the longs to gather.
Legend, you trying to persuade green investors on technical analysis? common man, you can do better than that, we all know only thing moving SP is catalyst and not the charts. There is no analysts on that site only technical jargon talk on averages. 🥱
Meirluc, my apologies. I am not good picking up on posts like that. :)
Meirluc, I am not convinced he is a long and he has been invested for 20 years, plus he just asked if we looked at the 10-Q finances? My goodness, either he just started investing or he is a short trying to play games with longs. Don’t have time for crazy posts like that.
JB please do sell so we don’t see any of your insane foolishness posts like this anymore,
Mico1, maybe temporarily but short of approval and or partnership do not expect much, we are all use to that by now. Different story if we were on NASDAQ or NYSE.
JT, are you sure about that, by the time anybody buys us out you I will put my bets on say the SP say starting at 6 and within 30 days be back under 2 bucks. The persons 1k shares valued at 60k now is worth under 20k in short order. You will be hard pressed to find successful RS without investors taking a bath. RS is worse than OTC, not to mention 75 percent of the investors would sell before RS took effect
chiugray, hoping approval gets us high enough and stable enough to get us off OTC, until then its wild wild west of the OTC's.
Chiugray, Only thing I do not see here that you mentioned is the dreaded 3 Letters "OTC" , new money investors will not be institutional type investors which we desperately need to compete with the hedges and mm's on a much larger dollar scale. Hoping NWBIO has a near-term plan to get us off OTC and should have a plan B and C if A fail's. I deem getting off OTC as crucial if any meaningful SP moves are too happen, IMO.
extrooper, agree, majority of mine I will be holding for long term growth outside of a buyout. Just saying for SP cycles I would not get too down on the wave of SP fluctuations even at these prices as mm's will do what they do to break the back if weak investors.
Good news is over the past year and several years a 30% pop in a week is not uncommon on various news and share price cycles as we wait for MHRA approval.
Thank you starric for the link from lancet.
" Recently, a phase III trial on
DC vaccine addition to SOC, DCVax-L, revealed a
significant extension of OS in both primary and recurrent GBM patients which was well-tolerated. Meanwhile, the phase I clinical trial of the DC vaccine
targeting GBM stem-like cells (GSC) in both newly
diagnosed and recurrent GBM patients76 reported
encouraging results for stem-like cell targeting strategy,
consistent with results of a previous DC vaccine phase II
study targeting GSC marker, CD133.77 Beyond the
standard mature DCs, an early-phase clinical trial
revealed that a-type 1 polarized DC (aDC1) is another
feasible DC type that can induce prolonged type-1 T-cell
response more efficiently in GBM patients."
dennidave , I been saying that about OTC when ATLnsider was giving his milestone list over a year ago, That to me really becomes the time when SP will finally bust out, my fear was always being on OTC on first approval and it looks like that may very well happen unless partnership or buy out happens before hand. OTC is where all the shark invested waters are and we are swimming in the midst of them. They continue to feed off us investors and will never be satisfied.
Flipper, I sent another email yesterday if he still holds onto that opinion and silence so far. Mani, its an email conversation I had with DI
FeMike, you picked a bad day for sarcasm, you never know with the players on this board.
mani, pretty sure ever one knows now by the way the way SP moves only 3 milestones matter (at least for me) : Approval, Partnership and Buyout
Underpar71, I did but getting the old silent treatment which is not the norm, so who knows what is going on behind the curtains. I ask to DI if he still holds to that opinion he gave me in April 2023
Yep same thought process DI had on milestones.
“Today marks a significant milestone....."